UNSPSC 51102900: Combination antimalarials

This classification denotes combination drugs that treat a protozoan disease caused in humans by four species of the plasmodium genus: plasmodium falciparum; plasmodium vivax; plasmodium ovale; and plasmodium malariae; and transmitted by the bite of an infected female mosquito of the genus anopheles, a disease called malaria, and hence the term ANTIMALARIALS. Typical combination antimalarial constituents are artemether, atovaquone, chloroquine, and pyrimethamine.

UNSPSC 51102900 Combination antimalarials is a Class code that in recent state and local procurement covers the supply of pharmaceutical products, including antimalarial compounds and related pharmaceutical items, to state health departments and county health agencies. State and local governments use this code for competitive procurement of medications and pharmaceutical supplies to support public health programs, emergency preparedness, and community health initiatives. The issuing bodies include state departments of public health and county health authorities.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under Invitation for Bid (IFB) process, with a total award amount of $2,999,999.11 over twelve months plus two optional renewal years. Seminole County, Florida released an IFB (26459723LAS) on June 30, 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building, with a two-year initial term and one-year renewal option; the bid deadline was July 26, 2023.